Investigation of drug evaluation model using Patient-Derived Cells (PDC)

被引:0
|
作者
Moriguchi, Misato [1 ]
Tsunesumi, Shinichiro [1 ]
Enoki, Shigenori [1 ]
Katayama, Seiichi [1 ]
Chiwaki, Fumiko [2 ]
Sasaki, Hiroki [2 ]
机构
[1] LSIM Safety Inst, Dept Pharmacol, Kamisu, Japan
[2] Natl Canc Ctr, Dept Translat Oncol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3017
引用
收藏
页码:1840 / 1840
页数:1
相关论文
共 50 条
  • [31] A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells
    Burkhardt, Matthew F.
    Martinez, Fernando J.
    Wright, Sarah
    Ramos, Carla
    Volfson, Dmitri
    Mason, Michael
    Garnes, Jeff
    Vu Dang
    Lievers, Jeffery
    Shoukat-Mumtaz, Uzma
    Martinez, Rita
    Gai, Hui
    Blake, Robert
    Vaisberg, Eugeni
    Grskovic, Marica
    Johnson, Charles
    Irion, Stefan
    Bright, Jessica
    Cooper, Bonnie
    Leane Nguyen
    Griswold-Prenner, Irene
    Javaherian, Ashkan
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2013, 56 : 355 - 364
  • [32] In silico modeling predicts drug sensitivity of patient-derived cancer cells
    Pingle, Sandeep C.
    Sultana, Zeba
    Pastorino, Sandra
    Jiang, Pengfei
    Mukthavaram, Rajesh
    Chao, Ying
    Bharati, Ila Sri
    Nomura, Natsuko
    Makale, Milan
    Abbasi, Taher
    Kapoor, Shweta
    Kumar, Ansu
    Usmani, Shahabuddin
    Agrawal, Ashish
    Vali, Shireen
    Kesari, Santosh
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [33] Investigation of immune-related diseases using patient-derived induced pluripotent stem cells
    Hirofumi Shoda
    Bunki Natsumoto
    Keishi Fujio
    Inflammation and Regeneration, 43
  • [34] Patient-derived tumor organoids to model drug response in gastric cancer
    Monreal, Anette Vistoso
    Zhao, Hua
    Sedghizadeh, Parish P.
    Lin, De-Chen
    CELL REPORTS MEDICINE, 2024, 5 (07)
  • [35] Patient-Derived Organoids as a Model for Predicting Drug Response in Pancreas Malignancies
    Hogenson, T.
    Phillips, W.
    Lenkiewicz, E.
    Almada, L.
    Koenig, A.
    Xie, H.
    Horn, I.
    Levy, M.
    Truty, M.
    Petersen, G. M.
    Barrett, M.
    Ma, W. W.
    Fernandez-Zapico, M. E.
    PANCREAS, 2020, 49 (10) : 1412 - 1412
  • [36] Gastric cancer patient-derived organoids model for the therapeutic drug screening
    Xu, Jiao
    Gong, Jin
    Li, Mengyang
    Kang, Ye
    Ma, Jinrong
    Wang, Xi
    Liang, Xiao
    Qi, Xin
    Yu, Bixin
    Yang, Jin
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2024, 1868 (04):
  • [37] Using patient-derived iPSCs to identify new drug treatments for JNCL
    Wiley, Luke A.
    Anfinson, Kristin
    Kaalberg, Emily E.
    Shrestha, Suruchi
    Swaminathan, Svetha
    Drack, Arlene V.
    Mullins, Robert
    Stone, Edwin M.
    Tucker, Budd A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [38] Modeling muscular diseases using patient-derived iPS cells
    Sakurai, Hidetoshi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S37 - S37
  • [39] Evaluation of predictive biomarkers for tankyrase inhibitor sensitivity using patient-derived colorectal cancer cells
    Chen, Mingjue
    Mashima, Tetsuo
    Muramatsu, Yukiko
    Shimizu, Yuki
    Nagayama, Satoshi
    Katayama, Ryohei
    Seimiya, Hiroyuki
    CANCER SCIENCE, 2022, 113 : 927 - 927
  • [40] Establishment and evaluation of patient-derived human cell lines using PDX mouse model for ICC
    Matsumoto, Takashi
    Hayashi, Hiromitsu
    Kariya, Ryusho
    Adachi, Yuki
    Kanemitsu, Kosuke
    Ogawa, Daisuke
    Yumoto, Shinsei
    Shiraishi, Yuta
    Takematsu, Toru
    Itoyama, Rumi
    Kitano, Yuki
    Nakagawa, Shigeki
    Mima, Kosuke
    Okabe, Hirohisa
    Okada, Seiji
    Baba, Hideo
    CANCER SCIENCE, 2024, 115 : 2047 - 2047